A pre-operative tricuspid annulus diameter >40 mm independently predicted moderate to severe tricuspid regurgitation at 1 year after aortic valve replacement (RR 2.12; 95% CI 1.26-3.54; P=0.004).
Cohort (n=116)
What are the predictors of post-operative progression of secondary tricuspid regurgitation in patients undergoing SAVR or TAVI for severe aortic stenosis?
Relative Risk: 2.12 (95% CI 1.26–3.54)
p-value: p=0.004
Aims: Secondary tricuspid regurgitation (STR) is commonly found in patients with aortic stenosis and is associated with increased morbidity. The study sought to evaluate the prevalence of pre-operative STR and its progression after surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI). Also, it sought to analyse the predictors of post-operative changes in STR. Methods and results: We prospectively evaluated 116 patients (aged 75.1 ± 9.8 years, predominantly male) who undergo SAVR or TAVI for severe aortic stenosis (AS) from September 2013 to April 2015. Patients with associated valve disease requiring intervention, significant coronary artery disease or left ventricular ejection fraction (LVEF) 40 mm was the only echocardiographic predictor of significant postoperative TR (relative risk (RR) = 2.12 1.26-3.54, P = 0.004). Right heart function and size were not independent predictors. Conclusion: Significant TR was present pre-operatively in 11.1% of patients. Post-operative progression was observed in 26.7% of patients. Only tricuspid annulus size >40 mm was an independent echocardiographic predictor of moderate to severe TR at the 1-year follow-up.
Dumont et al. (Fri,) conducted a cohort in severe symptomatic aortic stenosis (n=116). Tricuspid annulus diameter >40 mm vs. Tricuspid annulus diameter ≤40 mm was evaluated on moderate to severe tricuspid regurgitation at 1-year follow-up (RR 2.12, 95% CI 1.26-3.54, p=0.004). A pre-operative tricuspid annulus diameter >40 mm independently predicted moderate to severe tricuspid regurgitation at 1 year after aortic valve replacement (RR 2.12; 95% CI 1.26-3.54; P=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: